Quest Diagnostics (DGX) Financial Analysis & Valuation | Quarter Chart
Quest Diagnostics (DGX)
DGXPrice: $212.64
Fair Value: 🔒
🔒score
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other... more
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United ... more
Description
Shares
| Market Cap | $23.54B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | James E. Davis |
| IPO Date | 1996-12-17 | CAGR | 0.07% |
| Employees | 55,000 | Website | www.questdiagnostics.com |
| Div. Yield | 1.4% | Payout Ratio | 0.35% |
| Buy Back Yield | 1.75% | Total Yield | 3.15% |
DGX chart loading...
Fundamentals
Technicals
| Enterprise Value | $30.09B | P/E Ratio | 20.97 |
| Forward P/E | 18.22 | PEG Ratio | 1.52 |
| P/S Ratio | 2.27 | P/B Ratio | 3.46 |
| P/CF Ratio | 13.78 | P/FCF Ratio | 19.36 |
| EPS | $10.14 | EPS Growth 1Y | 14.27% |
| EPS Growth 3Y | 33.68% | EPS Growth 5Y | -31.28% |
| Revenue Growth 1Y | 11.03% | Gross Margin | 0.33% |
| Operating Margin | 0.14% | Profit Margin | 0.09% |
| ROE | 0.14% | ROA | 0.06% |
| ROCE | 0.11% | Current Ratio | 1.18 |
| Quick Ratio | 1.08 | Cash Ratio | 0.18 |
| Debt/Equity | 0.95 | Interest Coverage | 6.09 |
| Altman Z Score | 3.45 | Piotroski Score | 7 |